Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
76.2M
-
Number of holders
-
31
-
Total shares
-
10.5M
-
Shares change
-
+245K
-
Total reported value, excl. options
-
$80.8M
-
Value change
-
+$2.07M
-
Number of buys
-
10
-
Number of sells
-
-15
-
Price
-
$7.70
Significant Holders of Xenon Pharmaceuticals Inc. - COMMON STOCK (XENE) as of Q4 2016
31 filings reported holding XENE - Xenon Pharmaceuticals Inc. - COMMON STOCK as of Q4 2016.
Xenon Pharmaceuticals Inc. - COMMON STOCK (XENE) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.5M shares
of 76.2M outstanding shares and own 13.77% of the company stock.
Largest 10 shareholders include BVF INC/IL (3.04M shares), Capital World Investors (1.23M shares), ORBIMED ADVISORS LLC (1M shares), PERCEPTIVE ADVISORS LLC (740K shares), Tekla Capital Management LLC (700K shares), DAFNA Capital Management LLC (514K shares), Opaleye Management Inc. (405K shares), Invesco Private Capital, Inc. (401K shares), SPHERA FUNDS MANAGEMENT LTD. (328K shares), and Ghost Tree Capital, LLC (325K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.